Darkow, Theodore; Henk, Henry J.; Thomas, Simu K.; … - In: PharmacoEconomics 25 (2007) 6, pp. 481-496
Objectives: Identify treatment interruptions and non-adherence with imatinib; examine the clinical and patient characteristics related to treatment interruptions and non-adherence; and estimate the association between treatment interruptions and non-adherence with imatinib and healthcare costs for...